Three-step conversion of protected taxane ester to paclitaxel

Details for Australian Patent Application No. 2002303507 (hide)

International Classifications

Event Publications

12 December 2002 Complete Application Filed

Priority application(s): 09/843,235 25.04.01 US

17 April 2003 Application Open to Public Inspection

Published as AU-A-2002303507

22 July 2004 Assignment before Grant

NaPro Bio Therapeutics, Inc The application has been assigned to Mayne Pharma (USA) Inc

3 November 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.